nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—SLC6A3—Parkinson's disease	0.302	0.382	CbGaD
Citalopram—CYP2E1—Parkinson's disease	0.216	0.274	CbGaD
Citalopram—CYP2D6—Parkinson's disease	0.159	0.201	CbGaD
Citalopram—ABCB1—Parkinson's disease	0.113	0.143	CbGaD
Citalopram—SLC6A2—locus ceruleus—Parkinson's disease	0.00593	0.0905	CbGeAlD
Citalopram—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00469	0.0715	CbGeAlD
Citalopram—Escitalopram—SLC6A3—Parkinson's disease	0.00381	0.656	CrCbGaD
Citalopram—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00349	0.0532	CbGeAlD
Citalopram—HTR2C—telencephalic ventricle—Parkinson's disease	0.00337	0.0514	CbGeAlD
Citalopram—SLC6A2—autonomic nervous system—Parkinson's disease	0.00315	0.0481	CbGeAlD
Citalopram—SLC6A3—nerve—Parkinson's disease	0.0022	0.0335	CbGeAlD
Citalopram—Escitalopram—CYP2D6—Parkinson's disease	0.002	0.345	CrCbGaD
Citalopram—SLC6A2—nerve—Parkinson's disease	0.00177	0.027	CbGeAlD
Citalopram—SLC6A3—hindbrain—Parkinson's disease	0.00165	0.0251	CbGeAlD
Citalopram—SLC6A4—hindbrain—Parkinson's disease	0.00151	0.023	CbGeAlD
Citalopram—ADRA1A—hindbrain—Parkinson's disease	0.00124	0.0188	CbGeAlD
Citalopram—SLC6A3—brainstem—Parkinson's disease	0.000944	0.0144	CbGeAlD
Citalopram—HTR2C—brainstem—Parkinson's disease	0.000912	0.0139	CbGeAlD
Citalopram—SLC6A3—forebrain—Parkinson's disease	0.000911	0.0139	CbGeAlD
Citalopram—HTR2C—forebrain—Parkinson's disease	0.000881	0.0134	CbGeAlD
Citalopram—SLC6A4—brainstem—Parkinson's disease	0.000865	0.0132	CbGeAlD
Citalopram—SLC6A4—forebrain—Parkinson's disease	0.000835	0.0127	CbGeAlD
Citalopram—CHRM1—forebrain—Parkinson's disease	0.000832	0.0127	CbGeAlD
Citalopram—SLC6A2—brainstem—Parkinson's disease	0.000761	0.0116	CbGeAlD
Citalopram—SLC6A2—forebrain—Parkinson's disease	0.000735	0.0112	CbGeAlD
Citalopram—CYP2D6—hindbrain—Parkinson's disease	0.000727	0.0111	CbGeAlD
Citalopram—ADRA1A—brainstem—Parkinson's disease	0.000708	0.0108	CbGeAlD
Citalopram—CHRM1—cardiovascular system—Parkinson's disease	0.000703	0.0107	CbGeAlD
Citalopram—ADRA1A—forebrain—Parkinson's disease	0.000683	0.0104	CbGeAlD
Citalopram—HTR2C—medulla oblongata—Parkinson's disease	0.000636	0.0097	CbGeAlD
Citalopram—SLC6A3—midbrain—Parkinson's disease	0.000602	0.00917	CbGeAlD
Citalopram—SLC6A3—spinal cord—Parkinson's disease	0.000587	0.00895	CbGeAlD
Citalopram—HTR2C—midbrain—Parkinson's disease	0.000581	0.00887	CbGeAlD
Citalopram—ADRA1A—cardiovascular system—Parkinson's disease	0.000578	0.00881	CbGeAlD
Citalopram—HTR2C—spinal cord—Parkinson's disease	0.000567	0.00865	CbGeAlD
Citalopram—SLC6A4—midbrain—Parkinson's disease	0.000551	0.0084	CbGeAlD
Citalopram—SLC6A4—spinal cord—Parkinson's disease	0.000538	0.0082	CbGeAlD
Citalopram—SLC6A2—medulla oblongata—Parkinson's disease	0.000531	0.0081	CbGeAlD
Citalopram—HRH1—forebrain—Parkinson's disease	0.000529	0.00806	CbGeAlD
Citalopram—SLC6A3—head—Parkinson's disease	0.000522	0.00795	CbGeAlD
Citalopram—HTR2C—head—Parkinson's disease	0.000504	0.00769	CbGeAlD
Citalopram—SLC6A3—nervous system—Parkinson's disease	0.000495	0.00754	CbGeAlD
Citalopram—HTR2C—nervous system—Parkinson's disease	0.000478	0.00729	CbGeAlD
Citalopram—SLC6A4—head—Parkinson's disease	0.000478	0.00729	CbGeAlD
Citalopram—CHRM1—head—Parkinson's disease	0.000476	0.00726	CbGeAlD
Citalopram—SLC6A3—central nervous system—Parkinson's disease	0.000476	0.00726	CbGeAlD
Citalopram—SLC6A3—cerebellum—Parkinson's disease	0.000465	0.0071	CbGeAlD
Citalopram—HTR2C—central nervous system—Parkinson's disease	0.00046	0.00702	CbGeAlD
Citalopram—CYP2B6—cardiovascular system—Parkinson's disease	0.000458	0.00698	CbGeAlD
Citalopram—SLC6A4—nervous system—Parkinson's disease	0.000453	0.00691	CbGeAlD
Citalopram—CHRM1—nervous system—Parkinson's disease	0.000451	0.00688	CbGeAlD
Citalopram—SLC6A4—central nervous system—Parkinson's disease	0.000436	0.00665	CbGeAlD
Citalopram—CHRM1—central nervous system—Parkinson's disease	0.000435	0.00663	CbGeAlD
Citalopram—CYP2E1—cardiovascular system—Parkinson's disease	0.00043	0.00655	CbGeAlD
Citalopram—SLC6A2—head—Parkinson's disease	0.000421	0.00642	CbGeAlD
Citalopram—CYP2D6—brainstem—Parkinson's disease	0.000417	0.00636	CbGeAlD
Citalopram—CYP2D6—forebrain—Parkinson's disease	0.000402	0.00614	CbGeAlD
Citalopram—SLC6A2—nervous system—Parkinson's disease	0.000399	0.00608	CbGeAlD
Citalopram—ADRA1A—head—Parkinson's disease	0.000391	0.00596	CbGeAlD
Citalopram—SLC6A2—central nervous system—Parkinson's disease	0.000384	0.00586	CbGeAlD
Citalopram—SLC6A3—brain—Parkinson's disease	0.000378	0.00576	CbGeAlD
Citalopram—ADRA1A—nervous system—Parkinson's disease	0.000371	0.00566	CbGeAlD
Citalopram—CYP2E1—medulla oblongata—Parkinson's disease	0.000367	0.0056	CbGeAlD
Citalopram—HTR2C—brain—Parkinson's disease	0.000365	0.00557	CbGeAlD
Citalopram—ADRA1A—central nervous system—Parkinson's disease	0.000357	0.00544	CbGeAlD
Citalopram—ADRA1A—cerebellum—Parkinson's disease	0.000349	0.00532	CbGeAlD
Citalopram—SLC6A4—brain—Parkinson's disease	0.000346	0.00528	CbGeAlD
Citalopram—CHRM1—brain—Parkinson's disease	0.000345	0.00526	CbGeAlD
Citalopram—CYP2E1—spinal cord—Parkinson's disease	0.000327	0.00499	CbGeAlD
Citalopram—ABCB1—embryo—Parkinson's disease	0.000327	0.00499	CbGeAlD
Citalopram—CYP2B6—head—Parkinson's disease	0.00031	0.00473	CbGeAlD
Citalopram—SLC6A2—brain—Parkinson's disease	0.000305	0.00465	CbGeAlD
Citalopram—HRH1—head—Parkinson's disease	0.000303	0.00462	CbGeAlD
Citalopram—CYP2B6—nervous system—Parkinson's disease	0.000294	0.00448	CbGeAlD
Citalopram—CYP2E1—head—Parkinson's disease	0.000291	0.00444	CbGeAlD
Citalopram—ABCB1—forebrain—Parkinson's disease	0.000289	0.00441	CbGeAlD
Citalopram—HRH1—nervous system—Parkinson's disease	0.000287	0.00438	CbGeAlD
Citalopram—ADRA1A—brain—Parkinson's disease	0.000283	0.00432	CbGeAlD
Citalopram—CYP2B6—central nervous system—Parkinson's disease	0.000283	0.00432	CbGeAlD
Citalopram—HRH1—central nervous system—Parkinson's disease	0.000276	0.00421	CbGeAlD
Citalopram—CYP2E1—nervous system—Parkinson's disease	0.000276	0.00421	CbGeAlD
Citalopram—CYP2E1—central nervous system—Parkinson's disease	0.000266	0.00405	CbGeAlD
Citalopram—CYP2E1—cerebellum—Parkinson's disease	0.00026	0.00396	CbGeAlD
Citalopram—ABCB1—cardiovascular system—Parkinson's disease	0.000245	0.00373	CbGeAlD
Citalopram—CYP2D6—head—Parkinson's disease	0.00023	0.00351	CbGeAlD
Citalopram—CYP2B6—brain—Parkinson's disease	0.000225	0.00343	CbGeAlD
Citalopram—CYP3A4—nervous system—Parkinson's disease	0.000222	0.00338	CbGeAlD
Citalopram—HRH1—brain—Parkinson's disease	0.000219	0.00335	CbGeAlD
Citalopram—CYP2D6—nervous system—Parkinson's disease	0.000218	0.00333	CbGeAlD
Citalopram—CYP3A4—central nervous system—Parkinson's disease	0.000214	0.00326	CbGeAlD
Citalopram—CYP2E1—brain—Parkinson's disease	0.000211	0.00322	CbGeAlD
Citalopram—CYP2D6—central nervous system—Parkinson's disease	0.00021	0.00321	CbGeAlD
Citalopram—ABCB1—medulla oblongata—Parkinson's disease	0.000209	0.00319	CbGeAlD
Citalopram—CYP2D6—cerebellum—Parkinson's disease	0.000206	0.00313	CbGeAlD
Citalopram—ABCB1—midbrain—Parkinson's disease	0.000191	0.00291	CbGeAlD
Citalopram—ABCB1—spinal cord—Parkinson's disease	0.000186	0.00284	CbGeAlD
Citalopram—CYP2D6—brain—Parkinson's disease	0.000167	0.00255	CbGeAlD
Citalopram—ABCB1—head—Parkinson's disease	0.000166	0.00253	CbGeAlD
Citalopram—ABCB1—nervous system—Parkinson's disease	0.000157	0.0024	CbGeAlD
Citalopram—ABCB1—central nervous system—Parkinson's disease	0.000151	0.00231	CbGeAlD
Citalopram—ABCB1—cerebellum—Parkinson's disease	0.000148	0.00225	CbGeAlD
Citalopram—ABCB1—brain—Parkinson's disease	0.00012	0.00183	CbGeAlD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.7e-05	0.000123	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	1.7e-05	0.000122	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GBA—Parkinson's disease	1.68e-05	0.000121	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—DBH—Parkinson's disease	1.68e-05	0.000121	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.68e-05	0.000121	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	1.68e-05	0.000121	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	1.68e-05	0.000121	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	1.67e-05	0.00012	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	1.65e-05	0.000118	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—INSR—Parkinson's disease	1.63e-05	0.000117	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.61e-05	0.000116	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—OMD—Parkinson's disease	1.61e-05	0.000116	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.6e-05	0.000115	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—DDC—Parkinson's disease	1.59e-05	0.000114	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGF20—Parkinson's disease	1.58e-05	0.000114	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	1.58e-05	0.000113	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.57e-05	0.000113	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	1.55e-05	0.000112	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—DDC—Parkinson's disease	1.55e-05	0.000111	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FGB—Parkinson's disease	1.54e-05	0.000111	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	1.54e-05	0.000111	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.54e-05	0.000111	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	1.54e-05	0.00011	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	1.53e-05	0.00011	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.53e-05	0.00011	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.53e-05	0.00011	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	1.52e-05	0.00011	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	1.52e-05	0.000109	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	1.51e-05	0.000109	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.5e-05	0.000108	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.5e-05	0.000108	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	1.5e-05	0.000108	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.48e-05	0.000107	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.48e-05	0.000106	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.47e-05	0.000106	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—DDC—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.44e-05	0.000104	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.44e-05	0.000103	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.41e-05	0.000102	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—INSR—Parkinson's disease	1.41e-05	0.000101	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	1.39e-05	9.98e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.38e-05	9.91e-05	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.37e-05	9.88e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.35e-05	9.7e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.34e-05	9.64e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.34e-05	9.61e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.34e-05	9.6e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.33e-05	9.59e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGB—Parkinson's disease	1.33e-05	9.58e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.33e-05	9.56e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.33e-05	9.56e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.33e-05	9.53e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.32e-05	9.47e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	1.31e-05	9.44e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	1.31e-05	9.43e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.31e-05	9.42e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.31e-05	9.41e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	1.31e-05	9.39e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	1.31e-05	9.38e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MAOB—Parkinson's disease	1.3e-05	9.37e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—DBH—Parkinson's disease	1.3e-05	9.35e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.3e-05	9.35e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GBA—Parkinson's disease	1.3e-05	9.35e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.3e-05	9.34e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.3e-05	9.34e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CTGF—Parkinson's disease	1.29e-05	9.27e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.29e-05	9.25e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	1.29e-05	9.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.28e-05	9.24e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	1.28e-05	9.21e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.27e-05	9.14e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.26e-05	9.08e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	1.26e-05	9.06e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—DRD3—Parkinson's disease	1.24e-05	8.95e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.24e-05	8.92e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	1.24e-05	8.92e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—DDC—Parkinson's disease	1.24e-05	8.89e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.23e-05	8.83e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	1.22e-05	8.78e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	1.2e-05	8.64e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NQO1—Parkinson's disease	1.19e-05	8.54e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—TH—Parkinson's disease	1.17e-05	8.42e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.17e-05	8.39e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.16e-05	8.36e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	1.16e-05	8.35e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	1.16e-05	8.33e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.15e-05	8.29e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—TH—Parkinson's disease	1.15e-05	8.24e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.14e-05	8.2e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.13e-05	8.09e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.13e-05	8.09e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYCS—Parkinson's disease	1.12e-05	8.08e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	1.12e-05	8.06e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	1.12e-05	8.06e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	1.1e-05	7.94e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	1.1e-05	7.94e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.1e-05	7.91e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	1.09e-05	7.82e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	1.05e-05	7.56e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.05e-05	7.56e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.04e-05	7.48e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	1.04e-05	7.47e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—COMT—Parkinson's disease	9.95e-06	7.16e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	9.92e-06	7.14e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTP1—Parkinson's disease	9.91e-06	7.12e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.9e-06	7.12e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MAOA—Parkinson's disease	9.88e-06	7.11e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HMOX1—Parkinson's disease	9.77e-06	7.02e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—COMT—Parkinson's disease	9.75e-06	7.01e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CTGF—Parkinson's disease	9.74e-06	7e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTP1—Parkinson's disease	9.7e-06	6.98e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP2D6—Parkinson's disease	9.69e-06	6.96e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MAOA—Parkinson's disease	9.68e-06	6.96e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HMOX1—Parkinson's disease	9.57e-06	6.88e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NGF—Parkinson's disease	9.55e-06	6.87e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—DDC—Parkinson's disease	9.54e-06	6.86e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CTGF—Parkinson's disease	9.51e-06	6.84e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF2—Parkinson's disease	9.43e-06	6.78e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	9.4e-06	6.76e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ABCB1—Parkinson's disease	9.38e-06	6.74e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	9.25e-06	6.65e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ABCB1—Parkinson's disease	9.18e-06	6.6e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	9.12e-06	6.55e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTM1—Parkinson's disease	9.1e-06	6.55e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	9.09e-06	6.54e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	9.09e-06	6.53e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	9.08e-06	6.53e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.01e-06	6.48e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EDN1—Parkinson's disease	9.01e-06	6.48e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	8.98e-06	6.46e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NQO1—Parkinson's disease	8.98e-06	6.45e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CTGF—Parkinson's disease	8.96e-06	6.44e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	8.95e-06	6.43e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTM1—Parkinson's disease	8.92e-06	6.41e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP2E1—Parkinson's disease	8.86e-06	6.37e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TH—Parkinson's disease	8.85e-06	6.36e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	8.84e-06	6.36e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NQO1—Parkinson's disease	8.76e-06	6.3e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GPX1—Parkinson's disease	8.72e-06	6.27e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TH—Parkinson's disease	8.63e-06	6.21e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GPX1—Parkinson's disease	8.54e-06	6.14e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYCS—Parkinson's disease	8.49e-06	6.11e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APOE—Parkinson's disease	8.46e-06	6.08e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.35e-06	6e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYCS—Parkinson's disease	8.29e-06	5.96e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NGF—Parkinson's disease	8.28e-06	5.95e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.25e-06	5.94e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NGF—Parkinson's disease	8.25e-06	5.93e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TH—Parkinson's disease	8.14e-06	5.85e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	8.12e-06	5.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.11e-06	5.83e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MTHFR—Parkinson's disease	8.05e-06	5.78e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.03e-06	5.77e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	7.88e-06	5.67e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MTHFR—Parkinson's disease	7.88e-06	5.67e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	7.86e-06	5.65e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.81e-06	5.62e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	7.73e-06	5.56e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	7.73e-06	5.56e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CTGF—Parkinson's disease	7.59e-06	5.46e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—COMT—Parkinson's disease	7.52e-06	5.41e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOE—Parkinson's disease	7.49e-06	5.39e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTP1—Parkinson's disease	7.49e-06	5.38e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MAOA—Parkinson's disease	7.47e-06	5.37e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HMOX1—Parkinson's disease	7.38e-06	5.31e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—COMT—Parkinson's disease	7.34e-06	5.28e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOE—Parkinson's disease	7.34e-06	5.27e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOE—Parkinson's disease	7.33e-06	5.27e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTP1—Parkinson's disease	7.31e-06	5.25e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOE—Parkinson's disease	7.3e-06	5.25e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MAOA—Parkinson's disease	7.29e-06	5.24e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—INS—Parkinson's disease	7.22e-06	5.19e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HMOX1—Parkinson's disease	7.21e-06	5.18e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	7.19e-06	5.17e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ABCB1—Parkinson's disease	7.09e-06	5.09e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	7.07e-06	5.09e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NQO1—Parkinson's disease	6.99e-06	5.03e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—COMT—Parkinson's disease	6.92e-06	4.97e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TH—Parkinson's disease	6.89e-06	4.96e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.89e-06	4.95e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTM1—Parkinson's disease	6.88e-06	4.95e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.87e-06	4.94e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.79e-06	4.88e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.71e-06	4.83e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYCS—Parkinson's disease	6.62e-06	4.76e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX1—Parkinson's disease	6.59e-06	4.74e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.52e-06	4.69e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX1—Parkinson's disease	6.43e-06	4.62e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—INS—Parkinson's disease	6.4e-06	4.6e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.33e-06	4.55e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—INS—Parkinson's disease	6.27e-06	4.51e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—INS—Parkinson's disease	6.26e-06	4.5e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—INS—Parkinson's disease	6.24e-06	4.49e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—INS—Parkinson's disease	6.14e-06	4.42e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—Parkinson's disease	6.08e-06	4.37e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.06e-06	4.36e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.97e-06	4.29e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.93e-06	4.27e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—COMT—Parkinson's disease	5.86e-06	4.21e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.86e-06	4.21e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTP1—Parkinson's disease	5.83e-06	4.19e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MAOA—Parkinson's disease	5.82e-06	4.18e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—Parkinson's disease	5.75e-06	4.14e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—Parkinson's disease	5.66e-06	4.07e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.59e-06	4.02e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—Parkinson's disease	5.52e-06	3.97e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCB1—Parkinson's disease	5.52e-06	3.97e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.46e-06	3.92e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.4e-06	3.88e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	5.38e-06	3.87e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTM1—Parkinson's disease	5.36e-06	3.85e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	5.34e-06	3.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TH—Parkinson's disease	5.32e-06	3.82e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—Parkinson's disease	5.21e-06	3.74e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—Parkinson's disease	5.13e-06	3.69e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.11e-06	3.67e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.94e-06	3.55e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—INS—Parkinson's disease	4.84e-06	3.48e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—Parkinson's disease	4.74e-06	3.41e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—INS—Parkinson's disease	4.72e-06	3.39e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CASP3—Parkinson's disease	4.66e-06	3.35e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	4.65e-06	3.34e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—Parkinson's disease	4.63e-06	3.33e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	4.61e-06	3.32e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	4.57e-06	3.29e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	4.54e-06	3.27e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—COMT—Parkinson's disease	4.52e-06	3.25e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.5e-06	3.24e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.49e-06	3.23e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—INS—Parkinson's disease	4.45e-06	3.2e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.44e-06	3.19e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—Parkinson's disease	4.41e-06	3.17e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	4.28e-06	3.08e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	4.27e-06	3.07e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.26e-06	3.06e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	4.2e-06	3.02e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.14e-06	2.97e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.96e-06	2.85e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—INS—Parkinson's disease	3.77e-06	2.71e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.66e-06	2.63e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—Parkinson's disease	3.4e-06	2.45e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—Parkinson's disease	3.16e-06	2.27e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—INS—Parkinson's disease	2.91e-06	2.09e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—Parkinson's disease	2.73e-06	1.97e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—Parkinson's disease	2.73e-06	1.96e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	2.68e-06	1.93e-05	CbGpPWpGaD
